Universe Pharmaceuticals (UPC) Invested Capital (2020 - 2025)
Universe Pharmaceuticals' Invested Capital history spans 5 years, with the latest figure at $5.9 billion for Q3 2024.
- For Q3 2024, Invested Capital fell 78.9% year-over-year to $5.9 billion; the TTM value through Sep 2024 reached $5.9 billion, down 78.9%, while the annual FY2024 figure was $5.9 billion, 78.9% down from the prior year.
- Invested Capital for Q3 2024 was $5.9 billion at Universe Pharmaceuticals, down from $28.0 billion in the prior quarter.
- Across five years, Invested Capital topped out at $35.3 billion in Q3 2022 and bottomed at $20.8 million in Q3 2020.
- The 5-year median for Invested Capital is $5.9 billion (2024), against an average of $13.9 billion.
- The largest annual shift saw Invested Capital soared 75059.29% in 2022 before it crashed 78.9% in 2024.
- A 5-year view of Invested Capital shows it stood at $20.8 million in 2020, then surged by 125.99% to $47.0 million in 2021, then skyrocketed by 75059.29% to $35.3 billion in 2022, then decreased by 20.82% to $28.0 billion in 2023, then plummeted by 78.9% to $5.9 billion in 2024.
- Per Business Quant, the three most recent readings for UPC's Invested Capital are $5.9 billion (Q3 2024), $28.0 billion (Q3 2023), and $35.3 billion (Q3 2022).